- You have no notable absorption issues and can ingest food effectively
Together with the absence of symptoms associated with IGF-1-mediated effects such as fluid retention, tissue edema, or impaired glucose tolerance, these results demonstrate that AOD-9604 does not activate the growth hormone/IGF-1 pathway and therefore functions through an entirely appetite-independent mechanism
Recipient neuronal cells should be sensitive to glutamate, have enough energy to withstand normal stimulation, and remove glutamate at the appropriate rates from the right locations
Clinically relevant 50 mg strength High-purity pharmaceutical-grade compound Backed by preclinical metabolic science Integrates well with NAD optimization and fat-loss regimens No known hormonal effects
Ready to Boost Your Health and Energy
The small B12 injections show promising potential as they may serve as a hidden approach to reaching weight loss targets through their effects on energy metabolism